Company intelligence / Profile preview

Dementia UK

London, England, United Kingdom

Ownership: Private
Employees: ~95
Development stage: Other

Overview

Dementia UK provides specialist nursing care via Admiral Nurses for families affected by dementia, with recent growth efforts and the incorporation of YoungDementia UK. Dementia UK does not have a therapeutic or clinical trial pipeline[1][2][6].

Therapeutic areas: Neurology
Modalities: Non-pharmacological therapy (specialist dementia nursing, psychosocial intervention)
Industry: Non-Academic Healthcare

Partnerships

Collaborations with NHS trusts and healthcare entities for nurse deploymentparticipates in the Dementia UK Ecosystem (collaborating with UK Dementia Research Institute, Dementias Platform UK, and NIHR; but not pharmaceutical/drug R&D partnerships)

Beyond the preview

Go deeper on Dementia UK.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Dementia UK.

Explore the full profile